DCF — NEW HANOVER REGIONAL MEDICAL CENTER
Enterprise Value: $-3.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.5B
Enterprise Value
$-1.1B
PV of Cash Flows
$-2.5B
PV of Terminal Value
$-4.0B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.3B | $-238.2M | -19.0% | $-291.6M | $-265.1M |
| Year 2 | $1.3B | $-232.3M | -18.0% | $-287.3M | $-237.5M |
| Year 3 | $1.3B | $-225.9M | -17.0% | $-282.6M | $-212.3M |
| Year 4 | $1.4B | $-225.8M | -16.0% | $-284.2M | $-194.1M |
| Year 5 | $1.4B | $-229.0M | -16.0% | $-289.1M | $-179.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.2B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.19378977672550082
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5